Methods of identifying photodamage using gene expression

• US 20030152964A1
• Filed: 10/07/2002
• Published: 08/14/2003
• Est. Priority Date: 11/08/2001
• Status: Abandoned Application

• Current Assignee: Unilever Home & Personal Care Usa Division Of Conopco, Inc.
• Original Assignee: Unilever Home & Personal Care Usa Division Of Conopco, Inc.
• Inventors: Iobst, Susanne Teklits, Boyd, Charles, Urschitz, Johann, Schilling, Kurt Matthew
• Application Number:
  US10/266,138
• Publication Number:
  US 20030152964A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: C12Q 1/6883 for diseases caused by alterations of genetic material
• CPC Class Codes: C12Q 2600/158 Expression markers

Abstract

The present invention relates to polynucleotide sequences in gene arrays that function as markers of photodamage and a personal care method of detecting photodamage using the markers.

Claims

1. A personal care method of detecting photodamage comprising the steps of:

(A) using at least one marker of photodamage, the marker selected from one or more sequences selected from the group consisting of;

sequence No. 70, sequence No. 71, sequence No. 72, sequence No. 73, sequence No. 74, sequence No. 75, sequence No. 76, sequence No. 77, sequence No. 78, sequence No. 79, sequence No. 80, sequence No. 81, sequence No. 82, sequence No. 83, and sequence No. 84;

and

(b) detecting a change in the marker to determine the presence of photodamage.

2. The method of claim 1 wherein the detecting step (b) comprises the further step of:

(b1) comparing a first skin sample with a second skin sample to determine whether there is a change in the marker.

3. A personal care method for detecting a skin condition in an epidermal or dermal or total skin sample, the method comprising the steps of:

a) determining a first gene expression of a predetermined skin sample having a known skin condition;

b) determining a second gene expression of a second predetermined skin sample having no known skin condition; and

c) identifying a plurality of markers of a change in the first and second gene expressions, so that the plurality of markers identify the known skin condition.

4. The method of claim 3 wherein the identifying step (c) further comprises the step of:

(c1) determining the marker by assessing a change in gene expression between the first gene expression and the second gene expression.

5. The method of claim 3 wherein the known skin condition is selected from the conditions comprising:

photodamage, aging, dry skin, and oily skin.

6. The method of claim 3 wherein the known skin condition is photodamage and the plurality of markers are selected from the group consisting of sequence No. 70, sequence No. 71, sequence No. 72, sequence No. 73, sequence No. 74, sequence No. 75, sequence No. 76, sequence No. 77, sequence No. 78, sequence No. 79, sequence No. 80, sequence No. 81, sequence No. 82, sequence No. 83, and sequence No. 84.

Sequence Listing

<

110>

IOBST, Susanne T

SCHILLING, Kurt M

BOYD, Charles

URSCHITZ, Johann

<

120>

METHODS OF IDENTIFYING PHOTODAMAGE USING GENE EXPRESSION

<

130>

J6664US(ED;

EP/JVT)seqlis Sep. 13, 2002;

51 -84

<

140>

<

141>

<

150>

60/338,272

<

151>

2001-11-08

<

160>

34

<

170>

Patentln Ver. 2.1

<

210>

1

<

211>

11

<

212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #51 of Table I

<

400>

1

caaaaaaaaa a 11

<

210>

2

<

211>

10

<

212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #52 of Table I

<

400>

2

acgttaaaga 11

<

210>

3

<

211>

11

<

212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #53 of Table I

<

400>

3

acatcatcga t 11

<

210>

4

<

211>

11

<

212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #54 of Table I

<

400>

4

actccaaaaa a 11

<

210>

5

<

211>

11

<

212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #55 of Table I

<

400>

5

gaaatacagt t 11

<

210>

6

<

211>

11

<

212>

DNA

<

213>

Artificial Sequence <

220>

<

223>

Description of Artificial Sequence;

Seq. #56 of Table I

<

400>

6

gccaggagct a 11

<

210>

7

<

211>

11

<

212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #57 of Table I

<

400>

7

ctcctcacct g 11

<

210>

8

<

211>

11

<

212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #58 of Table I

<

400>

8

caataaactg a 11

<

210>

9

<

211>

11

<

212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #59 of Table I

<

400>

9

cagctcactg a 11

<

210>

10

<

211>

11

<

212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #60 of Table I

<

400>

10

caggacctgg t 11

<

210>

11

<

211>

11

<

212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #61 of Table I

<

400>

11

cccaacgcgc t 11

<

210>

12

<

211>

11

<

212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #62 of Table I

<

400>

12

ccctggcaat g 11

<

210>

13

<

211>

11

<

212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #63 of Table I

<

400>

13

ctgccaagtt g 11

<

210>

14

<

211>

11

<

212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #64 of Table I

<

400>

14

gcaaaacccc g 11

<

210>

15

<

211>

11

<

212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #65 of Table I

<

400>

15

ggaaaaaaaa a 11

<

210>

16

<

211>

11

<

212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #66 of Table I

<

400>

16

ggggcagggc c 11

<

210>

17

<

211>

11

<

212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #67 of Table I

<

400>

17

gtgcactgag c 11

<

210>

18

<

211>

11

<

212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #68 of Table I

<

400>

18

tctcccacac c 11

<

210>

19

<

211>

11

<

212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #69 of Table I

<

400>

19

cggggtggcc g 11

<

210>

20

<

211>

11

<

212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #70 of Table II

<

400>

20

acatttcaaa g 11

<

210>

21

<

211>

11

<

212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #71 of Table II

<

400>

21

cagctatttc a 11

<

210>

22

<

211>

11

<

212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #72 of Table II

<

400>

22

ggcccctcac c 11

<

210>

23

<

211>

11

<

212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #73 of Table II

<

400>

23

atccgcgagg c 11

<

210>

24

<

211>

11

<

212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #74 of Table II

<

400>

24

aacgcggcca a 11

<

210>

25

<

211>

11

<

212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #75 of Table II

<

400>

25

gagcagcgcc c 11

<

210>

26

<

211>

11

<

212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #76 of Table II

<

400>

26

aagaagatag a 11

<

210>

27

<

211>

11

<

212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #77 of Table II

<

400>

27

taaaaaaaaa a 11

<

210>

28

<

211>

11

<

212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #78 of Table II

<

400>

28

tcagactttt g 11

<

210>

29

<

211>

11

<

212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #79 of Table II

<

400>

29

ttggtgaagg a 11

<

210>

30

<

211>

11

21 212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #80 of Table II

<

400>

30

aactaacaaa a 11

<

210>

31

<

211>

11

<

212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #81 of Table II

<

400>

31

caataaatgt t 11

<

210>

32

<

211>

11

<

212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #82 of Table II

<

400>

32

gctcccagac t 11

<

210>

33

<

211>

11

<

212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #83 of Table II

<

400>

33

ggaagtttcg a 11

<

210>

34

<

211>

11

<

212>

DNA

<

213>

Artificial Sequence

<

220>

<

223>

Description of Artificial Sequence;

Seq. #84 of Table II

<

400>

34

tcaaaaatat a